Jonathan Eckard is a biopharma executive with 20 years of experience in corporate strategy and deal execution, specializing in oncology and metabolic diseases. He integrates deep scientific due diligence with a background in Wall Street equity research to lead M&A and licensing. He holds a Ph. D. from the NYU Grossman School of Medicine.
He frequently shares insights on biopharmaceutical regulatory changes, trade policies, and the impact of geopolitical events on the industrys supply chain. His posts demonstrate a keen interest in analyzing and explaining complex market and regulatory dynamics affecting life sciences companies, keeping his network informed on pivotal industry shifts.
His unique career path includes transitioning from a senior biotechnology analyst at top-tier investment banks like Barclays and Citi to C-suite roles in several biopharma companies.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.